Patent · US Active

Immunostimulatory compositions and methods of use thereof

US10029016B2 · kind B2 · utility

13Cited by
2References
36Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 2, 2015
Grant dateJul 24, 2018
Priority date
Expiry dateJul 2, 2035

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Lipid conjugates for enhanced delivery of cargo to the lymph nodes are disclosed. The lipid conjugates typically include three domains: a lipophilic domain that binds to albumin, a polar block domain, and a cargo such as a molecular adjuvant or immunostimulatory compound (such as an oligonucleotide) or antigenic peptide. Depending on the cargo, the length and compositions of the polar block can be tailored to push the equilibrium toward albumin binding, stable micelle formation, or cell insertion. The conjugates can be administered to a subject, for example, a subject with cancer or an infection, to induce or enhance a robust immune response in the subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.